Prostate carcinoma: defining therapeutic objectives and improving overall outcomes.
about
Current clinical challenges in prostate cancerRat PSP94 inhibits the growth and viability of the rat adenocarcinoma cell line PAIII in vitro.Symptomatic diagnosis of prostate cancer in primary care: a structured review.Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer.Prostate cancer clinical trial end points: "RECIST"ing a step backwards.(18)F-fluoride positron emission tomography/computed tomography and bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer patients: study protocol for a multicentre, diagnostic test accuracy studyDeveloping imaging strategies for castration resistant prostate cancerPathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway.EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study.Imaging metastatic bone disease from carcinoma of the prostateDevelopment of enzalutamide for metastatic castration-resistant prostate cancer.Neuroendocrine differentiation of prostate cancer.Analgesic efficacy of zoledronic acid and its effect on functional status of prostate cancer patients with metastasis.Automated Bone Scan Index as Predictors of Survival in Prostate CancerNitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
P2860
Q26866036-6B9C6153-2E1F-4731-B6F8-3BE056EDB14CQ33248405-67074EC5-FA7B-42D6-84BA-E70E808AF3D8Q34247769-512A4762-F6DA-4215-818F-20D23E37C7A9Q35070165-059AF21C-FC8C-4365-8667-9082316235F7Q35751894-545E8A54-422B-4BAF-8087-19401AFF590DQ35890956-15A43B3F-B3C8-409B-A465-5D63CDEBB9AFQ36152211-27A8EC6E-3931-4FDE-8AE2-D3F3279702A9Q36206304-CFE87129-7B52-473B-B9B6-DBF481091F0EQ37377297-05E21E47-6528-401D-A8B1-A498EEAC8CC8Q37605543-260DF228-B755-4C23-8F15-0E431E5B27B9Q38589130-650D08A6-1538-4E8F-86FF-E53D62E22341Q39179651-C4928911-F342-4A86-8352-C05AA30A4575Q41864229-26ECCF06-5F9B-434D-91B6-7211D0792E69Q42376456-E85D537A-AA1D-4F73-B038-C4665F1E73C2Q45247297-E3A47A13-9F2D-4231-A883-D8D22F0547A7
P2860
Prostate carcinoma: defining therapeutic objectives and improving overall outcomes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Prostate carcinoma: defining therapeutic objectives and improving overall outcomes.
@ast
Prostate carcinoma: defining therapeutic objectives and improving overall outcomes.
@en
type
label
Prostate carcinoma: defining therapeutic objectives and improving overall outcomes.
@ast
Prostate carcinoma: defining therapeutic objectives and improving overall outcomes.
@en
prefLabel
Prostate carcinoma: defining therapeutic objectives and improving overall outcomes.
@ast
Prostate carcinoma: defining therapeutic objectives and improving overall outcomes.
@en
P356
P1433
P1476
Prostate carcinoma: defining therapeutic objectives and improving overall outcomes.
@en
P2093
Howard I Scher
P304
P356
10.1002/CNCR.11151
P407
P433
P577
2003-02-01T00:00:00Z